Inter Pharma PCL (BKK:IP)
3.920
+0.020 (0.51%)
At close: Mar 13, 2026
Inter Pharma PCL Cash Flow Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 122.38 | 36.65 | 50.79 | 118.88 | 105.22 |
Depreciation & Amortization | 112.66 | 109.53 | 97.18 | 64.47 | 25.67 |
Other Amortization | 4.09 | 3.05 | 1.07 | 1.28 | 0.93 |
Loss (Gain) From Sale of Assets | 1.07 | 1.08 | 0.47 | 0.83 | 3.6 |
Asset Writedown & Restructuring Costs | 0.82 | 0.13 | 3.05 | - | - |
Loss (Gain) From Sale of Investments | 8.96 | 8.14 | 3.89 | 5.17 | 1.8 |
Loss (Gain) on Equity Investments | 1.23 | 1.59 | 2.27 | 0.77 | 0.08 |
Provision & Write-off of Bad Debts | -2.77 | - | - | - | - |
Other Operating Activities | 56.6 | 31.65 | 22.44 | 31.65 | 16.21 |
Change in Accounts Receivable | -15.63 | -15.63 | -43.82 | -43.02 | -138.36 |
Change in Inventory | -31.7 | 20.79 | -24.4 | -60.61 | -85.31 |
Change in Accounts Payable | 53.24 | -15.88 | 10.15 | 26.32 | 35.21 |
Change in Other Net Operating Assets | -3.05 | -3.25 | -1.68 | -2.63 | -6.62 |
Operating Cash Flow | 307.88 | 177.84 | 121.42 | 143.09 | -41.57 |
Operating Cash Flow Growth | 73.13% | 46.46% | -15.14% | - | - |
Capital Expenditures | -140.56 | -237.43 | -106.46 | -27.37 | -224.15 |
Sale of Property, Plant & Equipment | 2.39 | 1.54 | 0.05 | 0.25 | 2.8 |
Cash Acquisitions | -1.9 | -95.18 | - | -538.45 | -106.57 |
Sale (Purchase) of Intangibles | -23.13 | -24.03 | -37.63 | -22.6 | -13.69 |
Investment in Securities | -0.08 | -0.07 | -36.32 | -0.02 | -10.23 |
Other Investing Activities | -7.21 | 45.16 | -52.4 | 0.06 | 0.06 |
Investing Cash Flow | -170.49 | -310.01 | -232.77 | -588.13 | -351.79 |
Short-Term Debt Issued | 41.22 | 39.18 | 45 | 20 | 120 |
Long-Term Debt Issued | 29.8 | - | 6 | 200 | 139 |
Total Debt Issued | 71.02 | 39.18 | 51 | 220 | 259 |
Short-Term Debt Repaid | -1.8 | -5.4 | -47.6 | -112.06 | - |
Long-Term Debt Repaid | -96.17 | -96.64 | -171.43 | -79.68 | -23.19 |
Total Debt Repaid | -97.97 | -102.04 | -219.03 | -191.74 | -23.19 |
Net Debt Issued (Repaid) | -26.95 | -62.86 | -168.03 | 28.26 | 235.81 |
Issuance of Common Stock | 0 | - | - | 1,043 | 192.22 |
Common Dividends Paid | - | -12.97 | -67 | - | -4.83 |
Other Financing Activities | -14.31 | -19.62 | -17.83 | -23.55 | -8.28 |
Financing Cash Flow | -41.26 | -95.45 | -252.86 | 1,048 | 414.92 |
Foreign Exchange Rate Adjustments | -0.1 | -0.17 | 0.17 | -0.26 | -0.01 |
Net Cash Flow | 96.04 | -227.79 | -364.03 | 602.56 | 21.54 |
Free Cash Flow | 167.33 | -59.59 | 14.96 | 115.72 | -265.73 |
Free Cash Flow Growth | - | - | -87.07% | - | - |
Free Cash Flow Margin | 7.56% | -3.12% | 0.83% | 7.54% | -28.85% |
Free Cash Flow Per Share | 0.28 | -0.10 | 0.03 | 0.22 | -0.56 |
Cash Interest Paid | 18.84 | 19.62 | 24.03 | 23.05 | 7.67 |
Cash Income Tax Paid | 28.78 | 16.48 | 46.73 | 31.56 | 31.08 |
Levered Free Cash Flow | 91.71 | -96.13 | -52.37 | 39.75 | -317.63 |
Unlevered Free Cash Flow | 103.95 | -83.72 | -36.27 | 54.33 | -312.62 |
Change in Working Capital | 2.86 | -13.97 | -59.75 | -79.95 | -195.09 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.